X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Elder Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ELDER PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA ELDER PHARMA FULFORD INDIA/
ELDER PHARMA
 
P/E (TTM) x 398.8 -0.2 - View Chart
P/BV x 6.2 0.1 6,158.7% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 FULFORD INDIA   ELDER PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ELDER PHARMA
Jun-14
FULFORD INDIA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs942380 247.9%   
Low Rs450188 239.4%   
Sales per share (Unadj.) Rs691.4491.2 140.8%  
Earnings per share (Unadj.) Rs11.5-3.2 -360.2%  
Cash flow per share (Unadj.) Rs15.414.4 106.6%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.0376.5 100.9%  
Shares outstanding (eoy) m3.9020.54 19.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.6 174.1%   
Avg P/E ratio x60.7-89.3 -68.0%  
P/CF ratio (eoy) x45.319.7 229.9%  
Price / Book Value ratio x1.80.8 242.8%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,7145,833 46.5%   
No. of employees `0000.4NA-   
Total wages/salary Rs m5052,179 23.2%   
Avg. sales/employee Rs Th6,073.0NM-  
Avg. wages/employee Rs Th1,137.4NM-  
Avg. net profit/employee Rs Th100.7NM-  
INCOME DATA
Net Sales Rs m2,69610,089 26.7%  
Other income Rs m125257 48.9%   
Total revenues Rs m2,82210,346 27.3%   
Gross profit Rs m-46-792 5.9%  
Depreciation Rs m15361 4.2%   
Interest Rs m102,756 0.3%   
Profit before tax Rs m54-3,653 -1.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m10125 7.7%   
Profit after tax Rs m45-65 -68.4%  
Gross profit margin %-1.7-7.8 21.9%  
Effective tax rate %17.7-3.4 -516.0%   
Net profit margin %1.7-0.6 -255.9%  
BALANCE SHEET DATA
Current assets Rs m1,7389,240 18.8%   
Current liabilities Rs m5459,998 5.4%   
Net working cap to sales %44.3-7.5 -589.4%  
Current ratio x3.20.9 345.3%  
Inventory Days Days4846 104.7%  
Debtors Days Days460 7.2%  
Net fixed assets Rs m1210,124 0.1%   
Share capital Rs m39206 19.0%   
"Free" reserves Rs m1,4435,582 25.8%   
Net worth Rs m1,4827,734 19.2%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m2,07722,882 9.1%  
Interest coverage x6.7-0.3 -2,064.5%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.30.4 294.5%   
Return on assets %2.611.8 22.2%  
Return on equity %3.0-0.8 -356.9%  
Return on capital %4.322.3 19.3%  
Exports to sales %03.0 0.0%   
Imports to sales %24.50.4 5,723.5%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs m65943 1,529.7%   
Fx inflow Rs m17307 5.6%   
Fx outflow Rs m673125 537.2%   
Net fx Rs m-656181 -361.8%   
CASH FLOW
From Operations Rs m9011,754 0.8%  
From Investments Rs m105-561 -18.7%  
From Financial Activity Rs m-14-6,762 0.2%  
Net Cashflow Rs m1814,432 4.1%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 7.5 50.7%  
FIIs % 0.1 16.8 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 36.1 58.7%  
Shareholders   4,783 16,479 29.0%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   J.B.CHEMICALS  SUVEN LIFE  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare FULFORD INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - FRESENIUS KABI ONCO. COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS